Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara J Mason

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Addiction Medicine|July 20, 2011
Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacyBarbara J Mason, Philippe Lehert
Expert Review of Neurotherapeutics|November 14, 2007
Acamprosate in the treatment of alcohol dependence: clinical and economic considerationsBarbara J Mason, Rebecca Crean
CNS & Neurological Disorders Drug Targets|March 6, 2010
Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependenceBarbara J Mason, Charles J Heyser
Alcohol Research : Current Reviews|June 11, 2021
Alcohol Use Disorder: The Role of Medication in RecoveryBarbara J Mason, Charles J Heyser
Annual Review of Pharmacology and Toxicology|October 31, 2015
Existing and Future Drugs for the Treatment of the Dark Side of AddictionGeorge F Koob, Barbara J Mason
Expert Opinion on Drug Safety|December 22, 2009
The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependenceBarbara J Mason, Charles J Heyser
Current Topics in Behavioral Neurosciences|February 22, 2012
A translational approach to novel medication development for protracted abstinenceBarbara J Mason, Amanda E Higley
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 6, 2012
Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacyPascal Perney, Philippe Lehert, Barbara J Mason
JAMA Internal Medicine|July 9, 2014
Gabapentin treatment for alcohol dependence--replyBarbara J Mason, Vivian Goodell, Farhad Shadan
Expert Opinion on Investigational Drugs|December 16, 2017
Gabapentin for the treatment of alcohol use disorderBarbara J Mason, Susan Quello, Farhad Shadan
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Addiction Medicine|July 20, 2011
Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacyBarbara J Mason, Philippe Lehert
Expert Review of Neurotherapeutics|November 14, 2007
Acamprosate in the treatment of alcohol dependence: clinical and economic considerationsBarbara J Mason, Rebecca Crean
CNS & Neurological Disorders Drug Targets|March 6, 2010
Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependenceBarbara J Mason, Charles J Heyser
Alcohol Research : Current Reviews|June 11, 2021
Alcohol Use Disorder: The Role of Medication in RecoveryBarbara J Mason, Charles J Heyser
Annual Review of Pharmacology and Toxicology|October 31, 2015
Existing and Future Drugs for the Treatment of the Dark Side of AddictionGeorge F Koob, Barbara J Mason
Expert Opinion on Drug Safety|December 22, 2009
The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependenceBarbara J Mason, Charles J Heyser
Current Topics in Behavioral Neurosciences|February 22, 2012
A translational approach to novel medication development for protracted abstinenceBarbara J Mason, Amanda E Higley
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 6, 2012
Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacyPascal Perney, Philippe Lehert, Barbara J Mason
JAMA Internal Medicine|July 9, 2014
Gabapentin treatment for alcohol dependence--replyBarbara J Mason, Vivian Goodell, Farhad Shadan
Expert Opinion on Investigational Drugs|December 16, 2017
Gabapentin for the treatment of alcohol use disorderBarbara J Mason, Susan Quello, Farhad Shadan
Pageof 6